Green Cross Corp
KRX:006280
Green Cross Corp
KRX:006280
Price:
142 300
KRW
-1.39%
Market Cap:
₩1.7T
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Green Cross Corp
KRX:006280
|
KR |
|
Tokyo Chuo Auction Holdings Ltd
HKEX:1939
|
JP |
|
A
|
Apex Healthcare Bhd
KLSE:AHEALTH
|
MY |
|
Bharat Gears Ltd
NSE:BHARATGEAR
|
IN |
|
Yealink Network Technology Co Ltd
SZSE:300628
|
CN |
|
P
|
Parcel Technik SA
WSE:PTE
|
PL |
|
AlzChem Group AG
XETRA:ACT
|
DE |
|
P
|
Pod Point Group Holdings PLC
LSE:PODP
|
UK |
|
Platt Nera International Ltd
HKEX:1949
|
TH |
|
Zhejiang Tengen Electrics Co Ltd
SSE:605066
|
CN |
|
A
|
Anchorstone Holdings Ltd
HKEX:1592
|
HK |
|
J
|
Jutal Offshore Oil Services Ltd
HKEX:3303
|
CN |
|
Ryanair Holdings PLC
XETRA:RY4C
|
IE |
|
Payright Ltd
ASX:PYR
|
AU |
|
V
|
Vivid Games SA
WSE:VVD
|
PL |
|
T
|
TC Energy Corp
NYSE:TRP
|
CA |
Multiples-Based Value
The
Multiples-Based Value for
Green Cross Corp (006280)
under the Base Case is
hidden
KRW.
Compared with the current market price of 142 300 KRW, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Green Cross Corp Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
Green Cross Corp Competitors
Green Cross Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
|
Green Cross Corp
KRX:006280
|
1.6T KRW | 0.8 | -347.5 | 14.6 | 33 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
365B USD | 6 | 87.2 | 14.5 | 20.1 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188.6B USD | 5.1 | 24.4 | 14.2 | 14.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
172.5B USD | 5.9 | 20.3 | 12.7 | 15.6 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
111.8B USD | 9.3 | 28.3 | 21.2 | 22.2 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
78.9B USD | 5.5 | 17.5 | 13 | 14.8 | |
| NL |
|
argenx SE
XBRU:ARGX
|
41.9B EUR | 11.8 | 37.9 | 40.9 | 41.8 | |
| AU |
|
CSL Ltd
ASX:CSL
|
66.2B AUD | 3 | 32.8 | 11 | 13.9 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
